To safeguard human and environmental health in a cost effective manner, we must develop a mechanistic basis for predicting toxic risk and assessing environmental exposure. We will address aspects of these goals by developing an understanding of the biochemistry, regulation, and toxicological significance of hydrolytic pathways of metabolism. We have targeted two groups of enzymes both of which are induced by peroxisome proliferators and which add water to xenobiotics. Since the epoxide functionality is the reactive center of some of the most dangerous mutagens, carcinogens and toxins known, the cytosolic epoxide hydrolase (cEH) is targeted in objective I. Based on our recent isolation of the message and gene of the cEH, we will examine its regulation and subcellular targeting. Parallel approaches in photoaffinity labeling, amino acid modification, enzyme kinetics and site directed mutagenicity are being used to determine catalytic mechanism. This information will be used to design more effective substrates and inhibitors. All of the above technology will be used to test the hypothesis that the cEH has an endogenous role in the biosynthesis of diols and tetrahydrofuran diols of a variety of lipids including arachidonic acid. Similar approaches will be used to assess the in vitro and in vivo roles of cEH in ameliorating toxicity. Our second objective emphasizes the carboxylesterases which metabolize esters such as malathion, permethrin and a variety of pharmaceuticals. Similar techniques will be used. We will purify hepatic esterases using esterase specific affinity columns that we have designed based upon potent transition state mimics of the enzymes. Based on this work we will isolate cDNA and genomic clones as in objective I and use these to study the regulation of the enzymes. We are investigating the catalytic mechanism of esterases relying heavily on production of mutants in the baculovirus expression system. We are using a new class of spectral substrates yielding highly sensitive assays to monitor serum and tissue esterases following xenobiotic exposure. The above information will be used to extend our appreciation of the role of esterases in the metabolism on natural and man made toxins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES002710-15
Application #
2153187
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1980-12-01
Project End
1998-03-31
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
15
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Davis
Department
Zoology
Type
Schools of Earth Sciences/Natur
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Bastan, Idil; Ge, Xiao Na; Dileepan, Mythili et al. (2018) Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation. J Leukoc Biol 104:109-122
Lakkappa, Navya; Krishnamurthy, Praveen T; Yamjala, Karthik et al. (2018) Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development. J Pharm Biomed Anal 149:457-464
Guedes, A G P; Aristizabal, F; Sole, A et al. (2018) Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis. J Vet Pharmacol Ther 41:230-238
?ertíková Chábová, V?ra; Kujal, Petr; Škaroupková, Petra et al. (2018) Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Kidney Blood Press Res 43:329-349
Kodani, Sean D; Bhakta, Saavan; Hwang, Sung Hee et al. (2018) Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase. Bioorg Med Chem Lett 28:762-768
Rand, Amy A; Helmer, Patrick O; Inceoglu, Bora et al. (2018) LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide. Methods Mol Biol 1730:123-133
Swardfager, W; Hennebelle, M; Yu, D et al. (2018) Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target. Neurosci Biobehav Rev 87:56-66
Burmistrov, Vladimir; Morisseau, Christophe; Harris, Todd R et al. (2018) Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability. Bioorg Chem 76:510-527
Wang, Weicang; Yang, Jun; Zhang, Jianan et al. (2018) Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation. Proc Natl Acad Sci U S A 115:5283-5288
Burmistrov, Vladimir; Morisseau, Christophe; Pitushkin, Dmitry et al. (2018) Adamantyl thioureas as soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett 28:2302-2313

Showing the most recent 10 out of 450 publications